重庆医科大学附属第一医院心血管内科,重庆 400016
Received:16 November 2022,
Revised:2023-03-26,
Accepted:15 May 2023,
Published:28 June 2023
移动端阅览
谢思媛,Bryan Richard Sasmita,夏圳,等.晚期肺癌炎症指数预测房颤合并心衰患者预后的价值[J].重庆医科大学学报,2023,48(6):667-672.
Xie Siyuan,Richard Sasmita Bryan,Xia Zhen,et al.Value of advanced lung cancer inflammation index in predicting the prognosis of patients with atrial fibrillation and heart failure[J].Journal of Chongqing Medical University,2023,48(6):667-672.
谢思媛,Bryan Richard Sasmita,夏圳,等.晚期肺癌炎症指数预测房颤合并心衰患者预后的价值[J].重庆医科大学学报,2023,48(6):667-672. DOI: 10.13406/j.cnki.cyxb.003246.
Xie Siyuan,Richard Sasmita Bryan,Xia Zhen,et al.Value of advanced lung cancer inflammation index in predicting the prognosis of patients with atrial fibrillation and heart failure[J].Journal of Chongqing Medical University,2023,48(6):667-672. DOI: 10.13406/j.cnki.cyxb.003246.
目的
2
探讨晚期肺癌炎症指数(advanced lung cancer inflammation index,ALI)对心房颤动(atrial fibrillation,AF)合并心力衰竭(heart failure,HF)患者全因死亡的预测价值。
方法
2
收集重庆医科大学附属第一医院的AF合并HF(AF-HF)患者临床资料,使用受试者工作特征(receiver operating characteristic,ROC)曲线评估ALI对全因死亡预测的能力,采用约登指数算取ALI的截断值,根据患者入院时ALI值分组(ALI>16.99组,ALI≤16.99组),并用Kaplan-Meier曲线对2组生存时间进行检验,最后利用多因素Cox逐步回归,分析ALI对本人群全因死亡的影响,并将样本分为瓣膜性AF及非瓣膜性AF进行亚组分析。
结果
2
共纳入614名AF-HF患者,其中失访49名,对剩余565患者进行统计分析,其中ALI
>
16.99组370例,ALI≤16.99组
195例,ALI≤16.99组共出现全因死亡113例(57.9%),ALI
>
16.99组出现全因死亡104例(28.1%),ALI≤16.99组的年龄更大,脑钠肽(brain natriuretic peptide,BNP)、D-二聚体、中性粒细胞百分比、尿素氮、肌酐、超敏C反应蛋白(high sensitivity C-reactive protein,hs-CRP)、活化部分凝血活酶时间(activated partial thromboplastin time,APTT)、白细胞、纽约心脏病协会心功能分级(New York Heart Association,NYHA)及心房颤动抗凝治疗出血风险评分系统(HAS-BLED出血风险评分)评分更高,体质指数(body mass index,BMI)、血红蛋白、淋巴细胞计数、白蛋白(albumin,ALB)、总胆固醇、低密度脂蛋白、高密度脂蛋白更低,差异有统计学意义。ALI预测AF-HF患者发生全因死亡的曲线下面积为0.660(95%Cl=0.614~0.705,
P
<
0.001)。多因素Cox回归分析中,ALI≤16.99、肌酐、年龄
>
65岁、原发性高血压是AF-HF患者全因死亡的独立危险因素。亚组分析中,ALI≤16.99为瓣膜性及非瓣膜性AF-HF患者全因死亡的独立危险因素。
结论
2
ALI与AF-HF患者的全因死亡相关,ALI≤16.99是AF-HF患者全因死亡的独立危险因素。因此,ALI可能有助于评估AF-HF患者的预后。
Objective
2
To investigate the value of advanced lung cancer inflammation index(ALI) in predicting the all-cause mortality of patients with atrial fibrillation(AF) and heart failure(HF).
Methods
2
Related clinical data were collected from the patients with AF and HF in The First Affiliated Hospital of Chongqing Medical University,and the receiver operating characteristic(ROC) curve was used to assess the value of ALI in predicting all-cause mortality. Youden index was used to determine the cut-off value of ALI,and the patients were divided into ALI
>
16.99 group and ALI≤16.99 group according to the ALI value on admission. The Kaplan-Meier curve was used to analyze survival time,and finally the multivariate
Cox
stepwise regression analysis was used to investigate the influence of ALI on the all-cause mortality of this population. The samples were divided into valvular and non-valvular AF for subgroup analysis.
Results
2
A total of 614 patients with AF and HF were enrolled,among whom 49 patients were lost to follow-up,and a statistical analysis was performed for the remaining 565 patients,with 370 patients in the ALI
>
16.99 group and 195 patients in
the ALI≤16.99 group. There were 113 cases(57.9%) of all-cause mortality in the ALI≤16.99 group and 104 cases(28.1%) of all-cause mortality in the ALI
>
16.99 group. Compared with the ALI
>
16.99 group,the ALI≤16.99 group had significantly higher age,brain natriuretic peptide,D-dimer,percentage of neutrophils,blood urea nitrogen,creatinine,high-sensitivity C-reactive protein,activated partial thromboplastin time,white blood cell count,NYHA class,and HAS-BLED score,as well as significantly lower body mass index,hemoglobin,lymphocyte count,albumin,total cholesterol,low-density lipoprotein,and high-density lipoprotein(all
P
<
0.05). ALI had an area under the ROC curve of 0.660(95%CI=0.614-0.705,
P
<
0.001) in predicting all-cause mortality of patients with AF and HF. The multivariate
Cox
regression analysis showed that ALI≤16.99,creatinine,age
>
65 years,and primary hypertension were independent risk factors for all-cause mortality of patients with AF and HF,and the subgroup analysis showed that ALI≤16.99 was an independent risk factor for all-cause mortality in patients with valvular or non-valvular AF-HF.
Conclusion
2
ALI is associated with all-cause mortality in patients with AF-HF,and ALI≤16.99 is an independent risk factor for all-cause mortality in such patients. Therefore,ALI may help to assess the prognosis of patients with AF-HF.
Brundel BJJM , Ai X , Hills MT , et al . Atrial fibrillation [J ] . Nat Rev Dis Primers , 2022 , 8 ( 1 ): 21 .
Farmakis D , Chrysohoou C , Giamouzis G , et al . The management of atrial fibrillation in heart failure:an expert panel consensus [J ] . Heart Fail Rev , 2021 , 26 ( 6 ): 1345 - 1358 .
Schnabel RB , Yin XY , Gona P , et al . 50 year trends in atrial fibrillation prevalence,incidence,risk factors,and mortality in the Framingham Heart Study:a cohort study [J ] . Lancet , 2015 , 386 ( 9989 ): 154 - 162 .
He X , Zeng G , Feng J , et al . Investigation on readmission rate and influencing factors of chronic heart failure in some areas of Hunan province [J ] . J Hunan Normal Univ(Med Sci) , 2021 , 18 ( 1 ): 50 - 54 .
Huang C , Zhang S , Huang D , et al . Atrial fibrillation: current understanding and treatment recommendations-2018 [J ] . Chin J Cardiac Pacing Electrophysi , 2018 , 32 : 315 - 368 .
Hohmann C , Pfister R , Mollenhauer M , et al . Inflammatory cell infiltration in left atrial appendageal tissues of patients with atrial fibrillation and sinus rhythm [J ] . Sci Rep , 2020 , 10 ( 1 ): 1685 .
Scott L , Li N , Dobrev D . Role of inflammatory signaling in atrial fibrillation [J ] . Int J Cardiol , 2019 , 287 : 195 - 200 .
Benz AP , Aeschbacher S , Krisai P , et al . Biomarkers of inflammation and risk of hospitalization for heart failure in patients with atrial fibrillation [J ] . J Am Heart Assoc , 2021 , 10 ( 8 ): e019168 .
Rodríguez-Rodríguez E , López-Sobaler AM , Ortega RM , et al . Association between neutrophil-to-lymphocyte ratio with abdominal obesity and healthy eating index in a representative older Spanish population [J ] . Nutrients , 2020 , 12 ( 3 ): 855 .
Mountzios G , Samantas E , Senghas K , et al . Association of the advanced lung cancer inflammation index(ALI) with immune checkpoint inhibitor efficacy in patients with advanced non-small-cell lung cancer [J ] . ESMO Open , 2021 , 6 ( 5 ): 100254 .
Cheng J , Li QY , Xiao S , et al . The advanced lung cancer inflammation index predicts chemotherapy response and infection risk in multiple myeloma patients receiving induction chemotherapy [J ] . 2022 ,13: 1047326 ,
Kusunoki K , Toiyama Y , Okugawa Y , et al . The advanced lung cancer inflammation index predicts outcomes in patients with Crohn's disease after surgical resection [J ] . Colorectal Dis , 2021 , 23 ( 1 ): 84 - 93 .
Fan W , Zhang Y , Liu YX , et al . Nomograms based on the advanced lung cancer inflammation index for the prediction of coronary artery disease and calcification [J ] . Clin Appl Thromb Hemost , 2021 , 27 : 10760296211060455 .
Koniari I , Artopoulou E , Velissaris D , et al . Biomarkers in the clinical management of patients with atrial fibrillation and heart failure [J ] . J Geriatr Cardiol , 2021 , 18 ( 11 ): 908 - 951 .
El Iskandarani M , El Kurdi B , Murtaza G , et al . Prognostic role of albumin level in heart failure [J ] . Medicine , 2021 , 100 ( 10 ): e24785 .
Zhu ZW , Zhou SH . Leukocyte count and the risk of adverse outcomes in patients with HFpEF [J ] . BMC Cardiovasc Disord , 2021 , 21 ( 1 ): 333 .
Murphy SP , Kakkar R , McCarthy CP , et al . Inflammation in heart failure: JACC state-of-the-art review [J ] . J Am Coll Cardiol , 2020 , 75 ( 11 ): 1324 - 1340 .
Nowak WN , Deng JC , Ruan XZ , et al . Reactive oxygen species generation and atherosclerosis [J ] . Arterioscler Thromb Vasc Biol , 2017 , 37 ( 5 ): e41 - e52 .
Yang Y , Lv J , Jiang S , et al . The emerging role of Toll-like receptor 4 in myocardial inflammation [J ] . Cell Death Dis , 2016 , 7 ( 5 ): e2234 .
Morbach C , Beyersdorf N , Kerkau T , et al . Adaptive anti-myocardial immune response following hospitalization for acute heart failure [J ] . ESC Heart Fail , 2021 , 8 ( 4 ): 3348 - 3353 .
Jahng JW , Song EF , Sweeney G . Crosstalk between the heart and peripheral organs in heart failure [J ] . Exp Mol Med , 2016 , 48 ( 3 ): e217 .
Ridker PM , Libby P , MacFadyen JG , et al . Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality:analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study(CANTOS) [J ] . Eur Heart J , 2018 , 39 ( 38 ): 3499 - 3507 .
Roth ME , Chinn ME , Dunn SP , et al . Association of colchicine use for acute gout with clinical outcomes in acute decompensated heart failure [J ] . Clin Cardiol , 2022 , 45 ( 7 ): 733 - 741 .
Andreis A , Imazio M , Casula M , et al . Colchicine efficacy and safety for the treatment of cardiovascular diseases [J ] . Intern Emerg Med , 2021 , 16 ( 6 ): 1691 - 1700 .
Lv SB , Ru SC . The prevalence of malnutrition and its effects on the all-cause mortality among patients with heart failure:a systematic review and Meta-analysis [J ] . PLoS One , 2021 , 16 ( 10 ): e0259300 .
Sze S , Pellicori P , Kazmi S , et al . Prevalence and prognostic significance of malnutrition using 3 scoring systems among outpatients with heart failure [J ] . JACC , 2018 , 6 ( 6 ): 476 - 486 .
Cheng N , Dang AM , Lv NQ , et al . Malnutrition status in patients of very advanced age with nonvalvular atrial fibrillation and its impact on clinical outcomes [J ] . Nutr Metab Cardiovasc Dis , 2019 , 29 ( 10 ): 1101 - 1109 .
Liu ZY , Nguyen Khuong J , Borg Caruana C , et al . The prognostic value of elevated perioperative neutrophil-lymphocyte ratio in predicting postoperative atrial fibrillation after cardiac surgery:a systematic review and Meta-analysis [J ] . Heart Lung Circ , 2020 , 29 ( 7 ): 1015 - 1024 .
Pellicori P , Zhang J , Cuthbert J , et al . High-sensitivity C-reactive protein in chronic heart failure: patient characteristics,phenotypes,and mode of death [J ] . Cardiovasc Res , 2020 , 116 ( 1 ): 91 - 100 .
Seo M , Yamada T , Morita T , et al . P6215Prognostic value of advanced lung cancer inflammation index in patients with chronic heart failure:a prospective comparative study with cardiac I-123 metaiodobenzylguanidine imaging [J ] . Eur Heart J , 2018 , 39 ( Suppl 1 ): ehy566 .
Sugai T , Shishido T , Watanabe K , et al . Advanced lung cancer inflammation index(ALI) is a feasible prognostic marker in patients with heart failure [J ] . J Cardiac Fail , 2017 , 23 ( 10 ): S70 .
0
Views
5
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621
